Simon Bissonnette

Simon Bissonnette is a Université de Montréal alumnus, having completed a B.Sc in Biochemistry, M.Sc in Biomedical Sciences and a Ph.D. in Nutrition. In the latter, he investigated the role of apoB-containing lipoproteins in the induction of adipose tissue inflammation and type 2 diabetes risk factors in humans. Simon is a Fellow in Clinical Biochemistry at Université de Montréal since September 2019, training both at the McGill University Health Center (MUHC) and the Centre Hospitalier de l'Université de Montréal (CHUM).

Miranda Brun

Miranda Brun has a B.Sc in Honors Biochemistry from the University of Alberta. She completed her PhD in Experimental Oncology at the University of Alberta in 2015. Her graduate research focused on the regulation of gene expression in malignant brain tumors. Miranda joined the Department of Lab Medicine and Pathology at the University of Alberta as a Clinical Biochemistry Fellow in July, 2017 and will complete her fellowship in June 2020.

Angela Goulard

Angela Goulard is the Program Manager for Laboratory Accreditation at CPSA. She has over 25 years of Laboratory experience in Alberta and Saskatchewan as an MLT with a background in Transfusion Medicine and Quality.

Isolde Seiden Long

Dr. Seiden Long is Clinical Biochemist with Alberta Precision Laboratories, Clinical Associate Professor at the University of Calgary and a member of the CSA Z252, the CSA Technical Committee on Lab Quality Management Systems and SCC Mirror Committee (SMC) for ISO Technical Committee 212 (TC212), Clinical laboratory testing and in vitro diagnostic test systems. Since 2014, she has been working with the ISO TC212 Working Group 2 (Reference Systems) on the document drafting committee for an internationally standardized approach to Measurement Uncertainty Calculations which was published by ISO in 2019 in a new Technical Specification (ISO/TS 20194: Medical laboratories — Practical guidance for the estimation of measurement uncertainty). Dr. Seiden Long has accepted the position of project lead for future revisions of this document.

Julie Coffey

Julie Coffey has played a key role in the development of the IQMH accreditation program and its requirements since its inception in 2000, and to date has coordinated and conducted over 150 assessments of medical laboratories using the ISO 15189 standard in four Canadian provinces. She is a member of the CLSI expert panel on Quality Systems and actively participates on ISO TC 212. Julie is on a mission to help laboratory and diagnostic imaging professionals create processes that are purposeful, inclusive and that infuse a new outlook on quality. 

Edward Randell

Dr. Edward Randell is the Division Chief of Clinical Biochemistry at Eastern Health Authority, Professor of Laboratory Medicine with the Faculty of Medicine at Memorial University, and Director of Clinical Laboratories with Ministry of Health (Government of Newfoundland and Labrador) in the Province of Newfoundland and Labrador. He has worked almost 25 years as a Clinical Biochemist, and is actively involves in CSCC and IFCC activities. His research activities to date have led to over 100 articles in peer-reviewed journals focusing on clinical biochemistry, obesity, diabetes, and arthritis. He is also a Six Sigma black belt and has professional interests in quality management, process improvement, and improving laboratory test utilization.

Glen J. Nowak

Glen Nowak is a Professor of advertising and Public Relations at the University of Georgia's College of Journalism & Mass Communication and Director of the College's Center for Health and Risk Communication.  For over 25 years, he has provided senior-level leadership in health, crisis, and risk communications, including managing programs and doing communication research.  From 1998 to 2012, he was at the U.S. Centers for Disease Control and Prevention, serving six years as the Communications Director for its National Immunization Program and six years as the agency's Director of Media Relations.  He is an author or co-author of over 45 peer-reviewed journal articles.  He has an MA in journalism (1987) and a Ph.D. in mass communications (1990) from the University of Wisconsin-Madison.

Shannon Haymond

Shannon Haymond, PhD is Vice Chair for Computational Pathology at Ann and Robert H. Lurie Children’s Hospital of Chicago and Associate Professor of Pathology at Northwestern University, Feinberg School of Medicine. Dr. Haymond performs research and clinical testing using mass spectrometry methods, develops new assays, and applies data analytics to enable improved quality and efficiency. Her computational pathology efforts are aimed at building the capacity for advanced data analytics in laboratory medicine through innovations in infrastructure, education, and research to facilitate datainformed decision making for clinical care, operations, and quality assurance.

Yu Chen

Dr. Chen is the Chief and Medical Director of the Department of Laboratory Medicine, Dr. Everett Chalmers Regional Hospital and Upper River Valley Area, Horizon Health Network, which includes a full range of service of Laboratory Medicine and Pathology at a busy regional laboratory and 3 satellite labs in the Fredericton region, New Brunswick. He has published published over 50 research papers, and 50+ abstracts and meeting presentations. Dr Chen received several research awards from the AACC and the CSCC. He has been volunteered with several laboratory practice guidelines committees of CLSI, CSCC, and AACC Academy.

Robert Moore

First graduate of the Clinical Chemistry Training program at the University of Toronto.
Teacher of technologists, Examiner, Accreditation of training colleges.
Education of students in Clinical Chemistry, Medical Students, University of Toronto undergraduates, Examiner at the University of Toronto, refreshers courses in Clinical Chemistry, Medical practitioners, students in Chiropractic, Naturopathy, Homeopathy.
Founding Member of the Laboratory Proficiency Testing program in Ontario.
Ontario Society of Clinical Chemists executive
Canadian Society of Clinical Chemists executive and archives committee.
International class athlete on the road, track and cross country.

Nicole White-Al Habeeb

Nicole is a fellow of the Canadian Academy of Clinical Biochemistry (FCACB) and Clinical Biochemist at LifeLabs.  She completed her PhD at Memorial University followed by post-doctoral training at the University of Toronto.  She is a graduate of the Clinical Chemistry training program at the University of Toronto.  Nicole serves as a member of the Harmonized Reference Interval Working Group where most of her efforts are focused on the development and implementation of a common lipid report across Canada.  Additionally, she is a Councillor on the Ontario Society of Clinical Chemists Council.

Brock O'Neil, MD

Dr. O'Neil is a urologic oncologist and health services research. His clinical practice covers all aspects of surgical management of genitourinary cancers. His research focuses understanding the drivers of and how to reduce the use of low-value cancer services.

Zahraa Mohammed-Ali

Zahraa received her PhD in medical sciences, specializing in physiology and pharmacology, from McMaster University, Hamilton, ON, Canada. She then held a post-doctoral research position at Toronto General Hospital Research Institute where her projects involved developing mass spectrometry assays to test fibrosis markers in renal transplant patients. She is currently completing her second year in the University of Toronto clinical chemistry program.

Brad Langford PharmD

Bradley Langford is a Pharmacist Consultant with the Antimicrobial Stewardship Program at Public Health Ontario. In his role, he supports the advancement of antimicrobial stewardship in all sectors across the province. He was previously the Lead Antimicrobial Stewardship pharmacist at St. Joseph's Health Centre, Unity Health Toronto, and is now the Lead Antimicrobial Stewardship Pharmacist at Hotel Dieu Shaver in St. Catharine's. His research interests include evaluation of antibiotic stewardship outcomes and incorporating implementation science and knowledge translation to improve the impact of antimicrobial stewardship interventions.

Dan Beriault PhD FCACB

Daniel Beriault is a fellow of the Canadian Academy of Clinical Biochemists (FCACB) and the head of biochemistry at St Michael’s Hospital. He is a co-chair of the CSCC Utilization Management Special Interest Group and a member of the University of Toronto Laboratory Medicine Quality Council. Daniel completed his PhD in Biochemistry at McMaster University and the post-doctoral clinical biochemistry training at the University of Toronto. Daniel has a particular interest in lab utilization, sepsis, endocrinology and toxicology.

Vilte Barakauskas

Vilte is a clinical biochemist at BCCWH and a clinical faculty member in the Department of Pathology at UBC. She is interested in how the clinical laboratory impacts pediatric and perinatal healthcare and outcomes and her research interests span areas of laboratory medicine that impact test use, interpretation and quality. She is part of initiatives to develop pregnancy reference intervals both prospectively and retrospectively, including the PRISM study which is currently recruiting postpartum women and neonates.

Ashley Newbigging, BSC in Medical Laboratory Sciences

Ashley is currently completing her PhD in Laboratory Medicine and Pathology, at the University of Alberta. Her graduate work involves the design and development of analytical assays using synthetic DNA to detect nucleic acid and protein biomarkers with technically simple procedures. She received a Bachelor of Science in Medical Laboratory Sciences in 2014, also from the University of Alberta.

Ihssan Boutiauy

Dr. Ihssan Bouhtiauy received a BSc, MSc in Biochemistry from the University of Moncton and his PhD in Biomedical Science from the University of Montreal. He is a Clinical Biochemist at the Region 4 Hospital Corporation since 1992, Head of Biochemistry Department since 1995 and since 2008 head of Biochemistry Department at Health Network Vitalite in NB. He was also director (interim) of diagnostic services at the Region 4 2015-2016.
Dr. Bouhtiauy was certified by the Canadian Academy of Clinical Biochemistry.
He was Member of the Board of the Canadian Academy of Clinical Biochemistry (CACB), Chair of Awards Committee of CACB, and Examiner for the CACB, and Chair of the International Affairs Working Group and reviewer of the Clinical Biochemistry Journal.
Ihssan is a member of different committees at the local, provincial and national level. He is also involved in teaching at the University of Moncton Campus Edmundston and Campus Moncton. He has more than 70 presentations and publications under his name. In 2000 he completed an MBA at the University of Moncton. In 1997 he was awarded the CSCC International Visitors Award.
Ihssan is also involved a surveyor with Accreditation Canada at national and international level.

Daniel Gauthier

  • PhD in Experimental Medicine, Faculty of Medicine, McGill University in 2008 
  • DEPD in Clinical Biochemistry, Faculty of Medicine, Université de Montreal 2010
  • Clinical biochemist, Pierre-Boucher Hospital, CISSS Montérégie-Centre since 2010
  • Head of regional biochemistry service, CISSS Montérégie-Centre since 2017.

David Richardson

Dr. Richardson is an infectious diseases consultant and medical micorbiologist at William Osler Health System.  He has been fortunate in his career to collaborate with many excellent researchers and has several publications primarily relating to influenza vaccine effectiveness and gram-negative resistance.  He is a strong proponent of "choosing wisely" in health care.